Evidence map›Paper›PMID 17322377›Full record

ArticleThe American journal of pathology2007

Evidence of a role for lactadherin in Alzheimer's disease.

Jacques Boddaert, Kiyoka Kinugawa, Jean-Charles Lambert, Fatiha Boukhtouche, Joffrey Zoll, Régine Merval, Olivier Blanc-Brude, David Mann, Claudine Berr, José Vilar and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.International journal of molecular sciences · 2024
    Article
  4. Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Article
  6. The Role of Extracellular Vesicles in Efferocytosis.Mini reviews in medicinal chemistry · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Developmental roles of microglia: A window into mechanisms of disease.Developmental dynamics : an official publication of the American Association of Anatomists · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Jacques BoddaertInstitut National de la Santé et de la Recherche Médicale, Centre de Recherche Cardiovasculaire Lariboisière, Paris, France.
Kiyoka Kinugawa
Jean-Charles Lambert
Fatiha Boukhtouche
Joffrey Zoll
Régine Merval
Olivier Blanc-Brude
David Mann
Claudine Berr
José Vilar
Béatrice Garabedian
Nathalie Journiac
Dominique Charue
Jean-Sébastien Silvestre
Charles Duyckaerts
Philippe Amouyel
Jean Mariani
Alain Tedgui
Ziad Mallat
Inserm · FRCentre National de la Recherche Scientifique · FRManchester Academic Health Science Centre · GBSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactadherin is a secreted extracellular matrix protein expressed in phagocytes and contributes to the removal of apoptotic cells. We examined lactadherin expression in brain sections of patients with or without Alzheimer's disease and studied its role in the phagocytosis of amyloid beta-peptide (Abeta). Cells involved in Alzheimer's disease, including vascular smooth muscle cells, astrocytes, and microglia, showed a time-related increase in lactadherin production in culture. Quantitative analysis of the level of lactadherin showed a 35% reduction in lactadherin mRNA expression in the brains of patients with Alzheimer's disease (n = 52) compared with age-matched controls (n = 58; P = 0.003). Interestingly, lactadherin protein was detected in the brains of patients with Alzheimer's disease and controls, with low expression in areas rich in senile plaques and marked expression in areas without Abeta deposition. Using surface plasmon resonance, we observed a direct protein-protein interaction between recombinant lactadherin and Abeta 1-42 peptide in vitro. Lactadherin deficiency or its neutralization using specific antibodies significantly prevented Abeta 1-42 phagocytosis by murine and human macrophages. In conclusion, lactadherin plays an important role in the phagocytosis of Abeta 1-42 peptide, and its expression is reduced in Alzheimer's disease. Alterations in lactadherin production/function may contribute to the initiation and/or progression of Alzheimer's disease.

Indexed as

AgedAge FactorsAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAntigens, SurfaceAstrocytesCells, CulturedFemaleHumansImmunohistochemistryMacrophagesMaleMiceMicrogliaMilk ProteinsAmyloid beta-PeptidesAntigens, SurfaceMFGE8 protein, humanMilk Proteins

Identifiers

PMID17322377
PMCPMC1864868
OpenAlexW2038532623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.